Markets

IN8bio Consensus Price Target Raised 12% to $7.14

Cross-asset desk, Private Trade News (2026-10-03): IN8bio Consensus Price Target Raised 12% to $7.14 The average one-year price target for IN8bio (NASDAQCM:INAB) (DB:6JH0) has been revised to $7.14 / share.… Primary source: original at Nasdaq (nasdaq.com).

October 3, 2026 1:09 AM GMT · Nasdaq

The average one-year price target for IN8bio (NASDAQCM:INAB) (DB:6JH0) has been revised to $7.14 / share. This is an increase of 12.00% from the prior estimate of $6.38 dated September 11, 2026. These figures represent aggregate analyst targets compiled from multiple sources and

Read at source

Read also

MIRA Pharmaceuticals Consensus Price Target Increased by 16.67% to $3.57

Rogers Consensus Price Target Increased by 11.54% to $197.20

TPG Mortgage Investment Trust, Inc. - Corporate Bond Price Target Increased by 14.75% to $40.50

American starts letting customers mix cash and miles for tickets